Compromised LCAT function is associated with increased atherosclerosis.
about
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsHigh prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations.Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population studyThe HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice.Low high-density lipoprotein cholesterol: current status and future strategies for management.High Maternal Serum Estradiol Levels Induce Dyslipidemia in Human Newborns via a Hepatic HMGCR Estrogen Response ElementDo mutations causing low HDL-C promote increased carotid intima-media thickness?Novel HDL-directed pharmacotherapeutic strategies.HDL dysfunction in diabetes: causes and possible treatments.Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects.Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism.LCAT deficiency in mice is associated with a diminished adrenal glucocorticoid function.Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.Haptoglobin, inflammation and disease.High-density lipoprotein: a fall from grace?Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?Recombinant human lecithin-cholesterol acyltransferase Fc fusion: analysis of N- and O-linked glycans and identification and elimination of a xylose-based O-linked tetrasaccharide core in the linker region.Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.Genetics of HDL-C: a causal link to atherosclerosis?Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research.Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.HDL as a Causal Factor in Atherosclerosis: Insights from Human Genetics.The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction.Lecithin: cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the script.Clinical Implications of Lipid Genetics for Cardiovascular Disease.Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families.HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.A novel frameshift mutation of the lecithin:cholesterol acyltransferase (LCAT) gene associated with renal failure in familial LCAT deficiency.A Caucasian male with very low blood cholesterol and low apoA-II without evidence of atherosclerosis.Impact of serum cholesterol esterification rates on the development of diabetes mellitus in a general population
P2860
Q26774903-E370495A-D012-40CC-B41B-FDF19D1E9F1DQ30406862-1E07DD3B-1909-4233-A642-FB8F96B73F86Q33577884-29A414C4-6918-4FEC-9BF8-668CF34CA478Q33993233-7F8A07D9-0591-48D8-9414-8485ABDBDCC1Q34021570-77BDE6CD-0927-40E1-872A-F87FDE6897B8Q34062910-C36B40D9-C9A4-417D-8AE6-07E021675C3AQ34155049-E2CA86BE-CA06-4C60-8055-08116634DB8EQ34214772-981554F3-2CA6-402D-B4EB-D05C3F428031Q34334846-C07DC3C1-93E5-490F-9577-92601620ED6EQ35591159-98EBB705-FDFE-499B-B83B-B2E5ACD8BA20Q35688343-645115D5-E161-4126-9B75-363D94A64C5BQ35860020-05DCD13B-AFF5-46FD-A49B-5CBDED5F92BFQ35904110-8CC6E190-6803-4F53-91EE-4E4065E75FEFQ36027231-F9C500B7-E21A-4A02-A4DF-726763A2FD48Q36037988-CB493F14-9407-414B-8404-EA1C311DC76DQ36145188-42094B08-BE39-4181-9AA9-E1B825186687Q36361831-F50A899F-ED47-40C1-A8D0-7D0FA3ACBC5AQ36462085-AE11A48C-D375-4CA0-B504-9141CD453ABAQ36548371-F287DE78-9D3D-4B0C-86C7-58069803F90CQ36658359-8269F5F2-DB50-44C4-B44F-ADE851E63E89Q36723319-79376FD9-2B83-49D9-8DE3-E1A00E25AA2AQ37166350-99DBE75F-FECD-4A3C-9602-C07F2527766DQ37209767-2EDB6E62-798D-4B9C-A233-7142D313DCBCQ37224981-4D7B56B5-15DB-4F3E-BE00-70EB8A55ECECQ37350339-A6A93B9C-28A4-441C-A3FF-E5F604C8C61BQ37485026-A371AF4D-58F3-4B7F-A313-6CED22938A56Q37509653-44264F17-F615-4BF4-B82B-032647528595Q38099536-584C88F6-25B0-42E9-B824-6D9A3B3F8DECQ38111810-D2F1698D-1857-45F8-BA52-1E559BBBAF9EQ38675396-73AB73DF-94CE-4929-A0B4-F7231997C6CDQ38992139-5B01EA5A-D355-4350-A91D-0AB0EB919AE9Q42152420-05ED4514-2FB3-4D5B-8394-98976BB00FDDQ42540496-3D69A12F-61E9-42F4-ACBE-4687BD0299FEQ42575072-CEB61071-0E92-465A-9659-2D6C1231F057Q46281858-4CD7E088-F11B-4E89-8F1D-E9EF543DA7E2Q47657807-2FC5030F-237D-4C98-BE1F-93D0C1A66371Q51082527-346AC207-FB36-4DE1-BE22-9080E08B8851Q51756725-CF3C57FE-BBBF-4C63-8209-1672B47EA11CQ53575103-0E514006-BE2B-4889-9C41-2E3DFBA4F0C8Q57174314-993017E0-F3D0-4AC7-AF74-930AFF7007A5
P2860
Compromised LCAT function is associated with increased atherosclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Compromised LCAT function is associated with increased atherosclerosis.
@en
Compromised LCAT function is associated with increased atherosclerosis.
@nl
type
label
Compromised LCAT function is associated with increased atherosclerosis.
@en
Compromised LCAT function is associated with increased atherosclerosis.
@nl
prefLabel
Compromised LCAT function is associated with increased atherosclerosis.
@en
Compromised LCAT function is associated with increased atherosclerosis.
@nl
P2093
P1433
P1476
Compromised LCAT function is associated with increased atherosclerosis.
@en
P2093
Adriaan G Holleboom
Aeilko H Zwinderman
Anton Stalenhoef
Barbara A Hutten
Eric de Groot
G Kees Hovingh
Jan Albert Kuivenhoven
John J P Kastelein
Patrick Rol
Wilma Petersen
P304
P356
10.1161/CIRCULATIONAHA.105.540427
P407
P577
2005-08-01T00:00:00Z